✨ Medicines and Health Notices
11 AUGUST 2005
NEW ZEALAND GAZETTE, No. 123
Product: Hepsera
Active Ingredient: Adefovir dipivoxil 10mg
Dosage Form: Tablet
New Zealand Sponsor: Muir Hutchison Limited
Manufacturer: Patheon Inc, Mississauga, Ontario, Canada
Product: Lemoxol
Active Ingredient: Ceftazidime pentahydrate 1,160mg equivalent to ceftazidime 1,000mg
Dosage Form: Powder for injection
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Demo SA, Athens-Lamia, Kryoneri, Athens, Greece
Product: Lemoxol
Active Ingredient: Ceftazidime pentahydrate 2,320mg equivalent to ceftazidime 2,000mg
Dosage Form: Powder for injection
New Zealand Sponsor: Multichem NZ Limited
Manufacturer: Demo SA, Athens-Lamia, Kryoneri, Athens, Greece
Product: Paracetamol
Active Ingredient: Paracetamol 500mg
Dosage Form: Tablet
New Zealand Sponsor: BJM Distributors Limited
Manufacturer: Strides Arcolab Ltd, Indlawadi Cross, Anekal Taluk, Bangalore, India
Dated this 29th day of July 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go5214
Consent to the Distribution of a New Related Product
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the Schedule hereto:
Schedule
Product: Vicks VapoDrops Fresh Peppermint
Active Ingredients: Menthol 7.14mg
Peppermint oil 7.14mg
Dosage Form: Lozenge
New Zealand Sponsor: Procter & Gamble Distributing New Zealand
Manufacturer: Makson Health Care (Private) Limited, Mandideep, Raison District, Madya Pradesh, India
Dated this 5th day of August 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go5217
Mental Health (Compulsory Assessment and Treatment) Act 1992
Mental Health (Compulsory Assessment and Treatment) Act Notice 2005—Appointment of Directors of Area Mental Health Services
Pursuant to section 92 of the Mental Health (Compulsory Assessment and Treatment) Act 1992, I, Karen Olive Poutasi, Director-General of Health, give the following notice.
Notice
-
This notice shall be read together with the Mental Health (Compulsory Assessment and Treatment) Act Notice 2000—Appointment of Directors of Area Mental Health Services (“the principal notice”)*.
-
The Schedule to the principal notice is amended in respect of
"Area 7—Waikato"
by omitting the name and title
"Dr John Strachan, consultant psychiatrist, of Waikato"
and substituting the name and title
"Dr Jamshed Meher-Homji, consultant psychiatrist, of Hamilton."
Dated at Wellington this 4th day of August 2005.
KAREN O. POUTASI (DR), Director-General of Health.
*New Zealand Gazette, 31 August 2000, page 2963
go5205
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2005, No 123
Gazette.govt.nz —
NZ Gazette 2005, No 123
✨ LLM interpretation of page content
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social Welfare29 July 2005
Medicines Act, Hepsera, Lemoxol, Paracetamol, Distribution Consent, Health Regulations
- DON MATHESON, Deputy Director-General, Public Health
🏥 Consent to the Distribution of a New Related Product
🏥 Health & Social Welfare5 August 2005
Medicines Act, Vicks VapoDrops Fresh Peppermint, Distribution Consent, Health Regulations
- DON MATHESON, Deputy Director-General, Public Health
🏥 Appointment of Directors of Area Mental Health Services
🏥 Health & Social Welfare4 August 2005
Mental Health Act, Waikato, Director Appointment, Consultant Psychiatrist
- John Strachan (Doctor), Removed as Director of Area Mental Health Services
- Jamshed Meher-Homji (Doctor), Appointed as Director of Area Mental Health Services
- KAREN O. POUTASI (DR), Director-General of Health